Back
ProShares UltraShort MSCI Emerging Markets Vs. Aligos Therapeutics Industry Stock Comparison
Sell
29
EEV
ProShares UltraShort MSCI Emerging Markets
Last Price:
$14.00
Seasonality Move:
-1.65%
Buy
58
ALGS
Aligos Therapeutics
Last Price:
$5.84
Seasonality Move:
-8.99%
Sell
29
ProShares UltraShort MSCI Emerging Markets (EEV)
is a Sell
Is ProShares UltraShort MSCI Emerging Markets a Buy, Sell or Hold?
-
The current ProShares UltraShort MSCI Emerging Markets [EEV] share price is $13.87. The Score for EEV is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
EEV is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $5.84. The Score for ALGS is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
ALGS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EEV Stock Price Chart
What is ProShares UltraShort MSCI Emerging Markets's stock price today?
-
The ProShares UltraShort MSCI Emerging Markets share price today is $13.87The current trend is moderately bearish and EEV is experiencing slight buying pressure.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $5.84The current trend is relatively stagnant and ALGS is experiencing slight buying pressure.
EEV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Buy |
Relative Strength Index (14 RSI): | 32.6 | Sell |
Chaikin Money Flow: | 666 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.3 - 16.44) | Sell |
Bollinger Bands (100): | (15.07 - 17.39) | Sell |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.49 | Sell |
Relative Strength Index (14 RSI): | 48.41 | Sell |
Chaikin Money Flow: | 9269 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.6 - 5.72) | Buy |
Bollinger Bands (100): | (5.24 - 30.22) | Sell |
EEV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.25 | Sell |
20-day SMA: | 15.01 | Sell |
50-day SMA: | 15.79 | Sell |
200-day SMA: | 16.4 | Sell |
8-day EMA: | 14.2 | Sell |
20-day EMA: | 14.63 | Sell |
50-day EMA: | 12.47 | Buy |
200-day EMA: | 5.3 | Buy |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.32 | Buy |
20-day SMA: | 5.32 | Buy |
50-day SMA: | 7.14 | Sell |
200-day SMA: | 16.32 | Sell |
8-day EMA: | 5.52 | Buy |
20-day EMA: | 5.59 | Buy |
50-day EMA: | 8.44 | Sell |
200-day EMA: | 15.48 | Sell |
ProShares UltraShort MSCI Emerging Markets Earnings Growth & EEV Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.36 per share, a decrease next quarter of $0.07 per share, an increase this year of $3.67 per share, and a decrease next year of $1.88 per share.
ProShares UltraShort MSCI Emerging Markets Technical Analysis
May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |